183 related articles for article (PubMed ID: 9200179)
21. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
22. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of intrathecally administered interleukin-1beta on carrageenan-induced hyperalgesia and spinal c-Fos expression in rats.
Ji GC; Zhang YQ; Ma F; Cao XD; Wu GC
Neurosci Lett; 2002 Aug; 328(2):137-40. PubMed ID: 12133574
[TBL] [Abstract][Full Text] [Related]
24. The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia.
Perrot S; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Pain; 1998 Feb; 74(2-3):269-74. PubMed ID: 9520241
[TBL] [Abstract][Full Text] [Related]
25. Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected].
Rohde DS; Detweiler DJ; Basbaum AI
Neuroscience; 1996 May; 72(1):233-42. PubMed ID: 8730720
[TBL] [Abstract][Full Text] [Related]
26. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
Stanfa LC; Dickenson AH
Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
[TBL] [Abstract][Full Text] [Related]
28. Polyamine deprivation alters formalin-induced hyperalgesia and decreases morphine efficacy.
Kergozien S; Delcros JG; Desury D; Moulinoux JP
Life Sci; 1999; 65(21):2175-83. PubMed ID: 10576589
[TBL] [Abstract][Full Text] [Related]
29. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine.
Gogas KR; Cho HJ; Botchkina GI; Levine JD; Basbaum AI
Pain; 1996 Apr; 65(1):9-15. PubMed ID: 8826484
[TBL] [Abstract][Full Text] [Related]
31. Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation.
Perrot S; Guilbaud G; Kayser V
Pain; 1999 Nov; 83(2):249-57. PubMed ID: 10534597
[TBL] [Abstract][Full Text] [Related]
32. Behavioural evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in carrageenin-induced hyperalgesic rats.
Kayser V; Chen YL; Guilbaud G
Brain Res; 1991 Sep; 560(1-2):237-44. PubMed ID: 1760731
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive effects of A1 and A2 type botulinum toxins on carrageenan-induced hyperalgesia in rat.
Shin MC; Yukihira T; Ito Y; Akaike N
Toxicon; 2013 Mar; 64():12-9. PubMed ID: 23270755
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.
Eisenach JC; Gebhart GF
Anesthesiology; 1995 Nov; 83(5):1046-54. PubMed ID: 7486155
[TBL] [Abstract][Full Text] [Related]
35. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
36. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
Honoré P; Chapman V; Buritova J; Besson JM
Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
[TBL] [Abstract][Full Text] [Related]
37. Antinociceptive effects of locally administered morphine in infant rats.
Barr GA
Pain; 1999 May; 81(1-2):155-61. PubMed ID: 10353503
[TBL] [Abstract][Full Text] [Related]
38. C-fos antisense oligodeoxynucleotide decreases subcutaneous bee venom injection-induced nociceptive behavior and fos expression in the rat.
Wu SX; Wang W; Wang YY; Ni TS; Li YQ; Yew DT
Neurosignals; 2002; 11(4):224-30. PubMed ID: 12393948
[TBL] [Abstract][Full Text] [Related]
39. Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.
Abbadie C; Honoré P; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pharmacol; 1994 Jun; 258(3):215-27. PubMed ID: 8088356
[TBL] [Abstract][Full Text] [Related]
40. Formalin-evoked Fos expression in spinal cord is enhanced in morphine-tolerant rats.
Rohde DS; Detweiler DJ; Basbaum AI
Brain Res; 1997 Aug; 766(1-2):93-100. PubMed ID: 9359591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
